Government and Regulations
News
FDA reiterates hydroxychloroquine limitations for COVID-19
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...
News
Hydroxychloroquine Debate Rages in Federal Medicine
Concern over the controversial COVID-19 treatment led to a dispute between the Veterans Health Administration and the VA Inspector General.
Government and Regulations
Observations From Embedded Health Engagement Team Members
A joint embedded health engagement team (EHET) was created and executed as a test of an alternative health engagement method during Operation...
Latest News
U.S. hospitals facing severe challenges from COVID-19, HHS report says
Delayed test results also reduced hospitals’ ability to provide care by sidelining clinicians who reported COVID-19 symptoms.
Government and Regulations
Aerosolization of COVID-19 and Contamination Risks During Respiratory Treatments
Appropriate personal protective equipment, including fit-tested particulate respirators, should be worn when administering nebulized medications...
News
FDA provides flexibility to improve COVID-19 test availability
Laboratories developing tests who work with the appropriate state authorities will no longer need to pursue an emergency use authorization from...
Commentary
To Prevent Pernicious Political Activities: The Hatch Act and Government Ethics
The impeachment trial has concluded. By the time you read this editorial, Super Tuesday will be over. Then there will be...
Commentary
Breach of migrant youths’ confidentiality is unethical, unacceptable
In health care when patients cannot trust the science, its implementation, or is let down by the clinician, they are unlikely to benefit from...
News
FDA, FTC uniting to promote biosimilars
As part of their collaboration, the two agencies will be sponsoring a public workshop on March 9 to discuss...
News
Trump seeks to cut NIH, CDC budgets, some Medicare spending
The proposed budget also calls for changed to the medical liability system, including a cap of $250,000 on noneconomic damage awards.